NIKKEI 225
38,703.51 +213.34 (+0.55%) HANG SENG
18,476.80 +51.84 (+0.28%) CRUDE OIL
75.61 +0.06 (+0.08%) GOLD FUTURES
2,394.90 +4.00 (+0.17%) DOW
38,886.17 +78.84 (+0.20%) Bitcoin GBP
55,281.68 -301.64 (-0.54%)
NVO Jan 2026 92.500 put
| Previous close | 3.8500 |
| Open | 3.8500 |
| Bid | 2.4200 |
| Ask | 3.5000 |
| Strike | 92.50 |
| Expiry date | 2026-01-16 |
| Day's range | 3.8500 - 3.8500 |
| Contract range | N/A |
| Volume | |
| Open interest | 18 |
- Yahoo Finance Video
Can GLP-1 weight-loss drug manufacturers keep momentum up?
As GLP-1 weight-loss drugs have boosted several healthcare stocks, Jennison Associates Head of Global Equity Mark Baribeau joins Market Domination Overtime to discuss whether these companies can keep up the momentum. Baribeau points to Novo Nordisk (NVO) and Eli Lilly (LLY) as companies seeing major revenue growth and likely to split the market. He sees weight-loss and type 2 diabetes drugs as a "paradigm shift" that present huge opportunities for both companies. However, he notes that while consumer demand for these drugs is skyrocketing, Novo Nordisk and Eli Lilly "don't have the manufacturing capacity to keep up with demand. So the gating factor here is really supply. It's not demand." He adds that as manufacturing capacities expand, growth will accelerate, making the industry's backdrop look "very, very healthy." For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Melanie Riehl
Investor's Business DailyNvidia Stock, These Other Companies Make Waves As IBD Sector Leaders
Nvidia stock, along with Wingstop and Novo Nordisk, head the IBD's Sector Leaders list as all have brought healthy gains for investors.
- Investing.com
Shares in Wegovy-maker Novo Nordisk climb, touching record high levels
Investing.com -- Copenhagen-listed shares in Novo Nordisk (CSE:NOVOb) edged up by 3.8% on Thursday, touching a fresh record high.
